The DOI matches its Crossref record.
Riboflavin prophylaxis in pediatric and adolescent migraine
Open accessAbstract
Migraine is a common disorder in childhood and adolescence. Studies on adults show the effectiveness and tolerability of riboflavin in migraine prevention, while data on children are scarce. This retrospective study reports on our experience of using riboflavin for migraine prophylaxis in 41 pediatric and adolescent patients, who received 200 or 400 mg/day single oral dose of riboflavin for 3, 4 or 6 months. Attack frequency and intensity decreased (P < 0.01) during treatment, and these results were confirmed during the follow-up. A large number of patients (77.1%) reported that abortive drugs were effective for controlling ictal events. During the follow-up, 68.4% of cases had a 50% or greater reduction in frequency of attacks and 21.0% in intensity. Two patients had vomiting and increased appetite, respectively, most likely for causes unrelated to the use of riboflavin. In conclusion, riboflavin seems to be a well-tolerated, effective, and low-cost prophylactic treatment in children and adolescents suffering from migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Riboflavin: The Health Benefits of a Forgotten Natural Vitamin
Suwannasom, N., Kao, I., Pruß, A., Georgieva, R., & Bäumler, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030950 · Cited by 444
Riboflavin and health: A review of recent human research
Thakur, K., Tomar, S. K., Singh, A. K., Mandal, S., & Arora, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1145104 · Cited by 349
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
The metabolic face of migraine — from pathophysiology to treatment
Gross, E. C., Lisicki, M., Fischer, D., Sándor, P. S., & Schoenen, J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0255-4 · Cited by 262
Prophylaxis of migraine headaches with riboflavin: A systematic review
Thompson, D. F., & Saluja, H. S. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12548 · Cited by 101
Metadata
- Authors
- Condò, M., Posar, A., Arbizzani, A., & Parmeggiani, A.
- Venue
- The Journal of Headache and Pain
- Published
- 2009-08-01
- Volume
- 10
- Issue
- 5
- Pages
- 361-365
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- OpenAlex
- W1987470554
- Cited by
- 175
- References
- 0
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Riboflavin prophylaxis in pediatric and adolescent migraine. https://app.cochat.ai/papers/10.1007/s10194-009-0142-2
- The paper
- Condò, M., Posar, A., Arbizzani, A., & Parmeggiani, A. (2009). Riboflavin prophylaxis in pediatric and adolescent migraine. The Journal of Headache and Pain. https://doi.org/10.1007/s10194-009-0142-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.